We demonstrated the efficacy of ULBP2 CAR-T cells alone, and particularly in combination with PD-1 blockade, to inhibit tumor growth and promote survival, using GC cell lines and organoids, as well as CDX and PDX models. Here, ULBP2 is linked to gastric cancer.